Upcoming Dividend • May 06
Upcoming dividend of €0.07 per share Eligible shareholders must have bought the stock before 13 May 2026. Payment date: 18 May 2026. The company is not currently making a profit and there are not enough cash flows to support it either. Trailing yield: 0.4%. Lower than top quartile of Italian dividend payers (4.6%). Lower than average of industry peers (3.3%). Aankondiging • Apr 03
K+S Aktiengesellschaft, Annual General Meeting, May 12, 2026 K+S Aktiengesellschaft, Annual General Meeting, May 12, 2026, at 10:00 W. Europe Standard Time. New Risk • Mar 19
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 6.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. Aankondiging • Mar 17
K+S Aktiengesellschaft to Report Fiscal Year 2026 Results on Mar 11, 2027 K+S Aktiengesellschaft announced that they will report fiscal year 2026 results at 7:00 AM, Central European Standard Time on Mar 11, 2027 Declared Dividend • Mar 15
Dividend reduced to €0.07 Dividend of €0.07 is 53% lower than last year. Ex-date: 13th May 2026 Payment date: 15th May 2026 Dividend yield will be 0.4%, which is lower than the industry average of 2.8%. Aankondiging • Mar 13
K+S Aktiengesellschaft announces Annual dividend, payable on May 15, 2026 K+S Aktiengesellschaft announced Annual dividend of EUR 0.0700 per share payable on May 15, 2026, ex-date on May 13, 2026 and record date on May 14, 2026. Reported Earnings • Mar 12
Full year 2025 earnings released: €6.01 loss per share (vs €0.37 loss in FY 2024) Full year 2025 results: €6.01 loss per share (further deteriorated from €0.37 loss in FY 2024). Revenue: €3.65b (flat on FY 2024). Net loss: €1.08b (loss widened €1.01b from FY 2024). Revenue is forecast to grow 1.2% p.a. on average during the next 3 years, compared to a 6.7% growth forecast for the Chemicals industry in Italy. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 131 percentage points per year, which is a significant difference in performance. Aankondiging • Nov 17
K+S Aktiengesellschaft to Report Q3, 2026 Results on Nov 10, 2026 K+S Aktiengesellschaft announced that they will report Q3, 2026 results at 7:00 AM, Central European Standard Time on Nov 10, 2026 Reported Earnings • Nov 12
Third quarter 2025 earnings released: EPS: €0.013 (vs €0.15 loss in 3Q 2024) Third quarter 2025 results: EPS: €0.013 (up from €0.15 loss in 3Q 2024). Revenue: €879.1m (up 1.5% from 3Q 2024). Net income: €2.30m (up €28.7m from 3Q 2024). Profit margin: 0.3% (up from net loss in 3Q 2024). The move to profitability was primarily driven by lower expenses. Revenue is forecast to grow 2.0% p.a. on average during the next 3 years, compared to a 7.7% growth forecast for the Chemicals industry in Italy. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 114 percentage points per year, which is a significant difference in performance. Aankondiging • Aug 15
K+S Aktiengesellschaft to Report Q2, 2026 Results on Aug 12, 2026 K+S Aktiengesellschaft announced that they will report Q2, 2026 results on Aug 12, 2026 Reported Earnings • Aug 13
Second quarter 2025 earnings released: €9.68 loss per share (vs €0.034 loss in 2Q 2024) Second quarter 2025 results: €9.68 loss per share (further deteriorated from €0.034 loss in 2Q 2024). Revenue: €871.2m (flat on 2Q 2024). Net loss: €1.73b (loss widened €1.73b from 2Q 2024). Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 6.1% growth forecast for the Chemicals industry in Italy. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 104 percentage points per year, which is a significant difference in performance. Aankondiging • May 15
K+S Aktiengesellschaft to Report Q1, 2026 Results on May 11, 2026 K+S Aktiengesellschaft announced that they will report Q1, 2026 results on May 11, 2026 Reported Earnings • May 14
First quarter 2025 earnings released: EPS: €0.48 (vs €0.10 in 1Q 2024) First quarter 2025 results: EPS: €0.48 (up from €0.10 in 1Q 2024). Revenue: €964.7m (down 2.4% from 1Q 2024). Net income: €85.5m (up 360% from 1Q 2024). Profit margin: 8.9% (up from 1.9% in 1Q 2024). Revenue is forecast to grow 1.9% p.a. on average during the next 3 years, compared to a 6.1% growth forecast for the Chemicals industry in Italy. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 82 percentage points per year, which is a significant difference in performance. Upcoming Dividend • May 08
Upcoming dividend of €0.15 per share Eligible shareholders must have bought the stock before 15 May 2025. Payment date: 19 May 2025. The company is not currently making a profit but it is cash flow positive. Trailing yield: 1.0%. Lower than top quartile of Italian dividend payers (5.6%). Lower than average of industry peers (2.6%). Declared Dividend • Apr 07
Dividend reduced to €0.15 Dividend of €0.15 is 79% lower than last year. Ex-date: 15th May 2025 Payment date: 19th May 2025 Dividend yield will be 1.2%, which is lower than the industry average of 2.8%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months. However, the dividend is well covered by cash flows (39% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. Aankondiging • Mar 15
K+S Aktiengesellschaft to Report Fiscal Year 2025 Results on Mar 12, 2026 K+S Aktiengesellschaft announced that they will report fiscal year 2025 results on Mar 12, 2026 Reported Earnings • Mar 13
Full year 2024 earnings released: EPS: €1.12 (vs €1.12 in FY 2023) Full year 2024 results: EPS: €1.12 (down from €1.12 in FY 2023). Revenue: €3.65b (down 5.7% from FY 2023). Net loss: €66.8m (down 132% from profit in FY 2023). Revenue is forecast to stay flat during the next 3 years compared to a 6.4% growth forecast for the Chemicals industry in Italy. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 65 percentage points per year, which is a significant difference in performance. New Risk • Jan 31
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 5.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 491% Cash payout ratio: 103% Minor Risks Share price has been volatile over the past 3 months (5.6% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.7% net profit margin). New Risk • Nov 15
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 5.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 491% Cash payout ratio: 103% Minor Risks Share price has been volatile over the past 3 months (5.2% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.7% net profit margin). Reported Earnings • Nov 15
Third quarter 2024 earnings released: €0.15 loss per share (vs €0.26 loss in 3Q 2023) Third quarter 2024 results: €0.15 loss per share (improved from €0.26 loss in 3Q 2023). Revenue: €866.2m (down 1.7% from 3Q 2023). Net loss: €26.4m (loss narrowed 45% from 3Q 2023). Revenue is forecast to stay flat during the next 3 years compared to a 7.8% growth forecast for the Chemicals industry in Italy. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 63 percentage points per year, which is a significant difference in performance. Aankondiging • Nov 15
K+S Aktiengesellschaft to Report Q3, 2025 Results on Nov 11, 2025 K+S Aktiengesellschaft announced that they will report Q3, 2025 results on Nov 11, 2025 Reported Earnings • Aug 15
Second quarter 2024 earnings released: €0.034 loss per share (vs €0.24 loss in 2Q 2023) Second quarter 2024 results: €0.034 loss per share (improved from €0.24 loss in 2Q 2023). Revenue: €873.8m (up 5.8% from 2Q 2023). Net loss: €6.10m (loss narrowed 87% from 2Q 2023). Revenue is forecast to grow 1.2% p.a. on average during the next 3 years, compared to a 7.9% growth forecast for the Chemicals industry in Italy. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings. Aankondiging • Aug 14
K+S Aktiengesellschaft to Report Q2, 2025 Results on Aug 12, 2025 K+S Aktiengesellschaft announced that they will report Q2, 2025 results on Aug 12, 2025 Aankondiging • May 14
K+S Aktiengesellschaft to Report Q1, 2025 Results on May 13, 2025 K+S Aktiengesellschaft announced that they will report Q1, 2025 results on May 13, 2025 Reported Earnings • May 13
First quarter 2024 earnings released: EPS: €0.10 (vs €1.38 in 1Q 2023) First quarter 2024 results: EPS: €0.10 (down from €1.38 in 1Q 2023). Revenue: €988.0m (down 17% from 1Q 2023). Net income: €18.6m (down 93% from 1Q 2023). Profit margin: 1.9% (down from 22% in 1Q 2023). Revenue is forecast to grow 1.1% p.a. on average during the next 3 years, compared to a 7.9% growth forecast for the Chemicals industry in Italy. Over the last 3 years on average, earnings per share has increased by 14% per year whereas the company’s share price has increased by 12% per year. Declared Dividend • Mar 17
Dividend of €0.70 announced Shareholders will receive a dividend of €0.70. Ex-date: 15th May 2024 Payment date: 17th May 2024 Dividend yield will be 5.3%, which is higher than the industry average of 2.8%. Sustainability & Growth Dividend is covered by both earnings (62% earnings payout ratio) and cash flows (37% cash payout ratio). The dividend has increased by an average of 11% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to decline by 65% over the next 3 years. Since a fall of 31% would increase the payout ratio to a potentially unsustainable range, the dividend may be at risk. Aankondiging • Mar 15
K+S Aktiengesellschaft to Report Fiscal Year 2024 Results on Mar 13, 2025 K+S Aktiengesellschaft announced that they will report fiscal year 2024 results on Mar 13, 2025 Reported Earnings • Mar 15
Full year 2023 earnings released: EPS: €1.12 (vs €7.88 in FY 2022) Full year 2023 results: EPS: €1.12 (down from €7.88 in FY 2022). Revenue: €3.87b (down 32% from FY 2022). Net income: €209.9m (down 86% from FY 2022). Profit margin: 5.4% (down from 27% in FY 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to stay flat during the next 3 years compared to a 5.7% growth forecast for the Chemicals industry in Italy. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Jan 08
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to €13.77, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 16x in the Chemicals industry in Europe. Total returns to shareholders of 49% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €8.84 per share. Reported Earnings • Nov 15
Third quarter 2023 earnings released: €0.25 loss per share (vs €1.48 profit in 3Q 2022) Third quarter 2023 results: €0.25 loss per share (down from €1.48 profit in 3Q 2022). Revenue: €880.8m (down 40% from 3Q 2022). Net loss: €47.6m (down 117% from profit in 3Q 2022). Revenue is expected to decline by 3.5% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Italy are expected to grow by 6.1%. Over the last 3 years on average, earnings per share has increased by 69% per year but the company’s share price has only increased by 30% per year, which means it is significantly lagging earnings growth. Aankondiging • Aug 15
K+S Aktiengesellschaft to Report Q1, 2024 Results on May 13, 2024 K+S Aktiengesellschaft announced that they will report Q1, 2024 results at 7:00 AM, Central European Standard Time on May 13, 2024 Reported Earnings • Aug 13
Second quarter 2023 earnings released: €0.24 loss per share (vs €1.94 profit in 2Q 2022) Second quarter 2023 results: €0.24 loss per share (down from €1.94 profit in 2Q 2022). Revenue: €825.8m (down 45% from 2Q 2022). Net loss: €45.3m (down 112% from profit in 2Q 2022). Revenue is expected to decline by 4.1% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Europe are expected to grow by 3.1%. Over the last 3 years on average, earnings per share has increased by 76% per year but the company’s share price has only increased by 44% per year, which means it is significantly lagging earnings growth. Aankondiging • Aug 11
K+S Aktiengesellschaft to Report Q2, 2024 Results on Aug 14, 2024 K+S Aktiengesellschaft announced that they will report Q2, 2024 results on Aug 14, 2024 New Risk • Jul 20
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 4.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 78% per year for the foreseeable future. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (4.8% average weekly change). Profit margins are more than 30% lower than last year (26% net profit margin). Upcoming Dividend • May 04
Upcoming dividend of €1.00 per share at 5.8% yield Eligible shareholders must have bought the stock before 11 May 2023. Payment date: 15 May 2023. Payout ratio is a comfortable 13% and this is well supported by cash flows. Trailing yield: 5.8%. Within top quartile of Italian dividend payers (5.2%). Higher than average of industry peers (3.9%). Reported Earnings • Mar 16
Full year 2022 earnings released: EPS: €7.88 (vs €11.35 in FY 2021) Full year 2022 results: EPS: €7.88 (down from €11.35 in FY 2021). Revenue: €5.68b (up 77% from FY 2021). Net income: €1.51b (down 31% from FY 2021). Profit margin: 27% (down from 68% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is expected to decline by 6.9% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Europe are expected to grow by 2.6%. Over the last 3 years on average, earnings per share has increased by 79% per year but the company’s share price has only increased by 45% per year, which means it is significantly lagging earnings growth. Aankondiging • Jan 27
K+S Aktiengesellschaft (XTRA:SDF) agreed to acquire 75% stake in Fertilizer business of Industrial Commodities Holdings (Pty) Ltd (ICH). K+S Aktiengesellschaft (XTRA:SDF) agreed to acquire 75% stake in Fertilizer business of Industrial Commodities Holdings (Pty) Ltd (ICH) on January 26, 2023. The new business will operate under the name Fertiva (Pty) Ltd. The balance of 25% of shares in Fertiva will be held by two former ICH shareholders, who will now be a part of the Fertiva management team. The closing of the transaction remains subject to the fulfillment of a number of conditions, including obtaining required regulatory approvals and is expected to close during the second quarter of 2023. Aankondiging • Jan 22
K+S Aktiengesellschaft Appoints Carin-Martina Tröltzsch as Member of the Board of Executive Directors, Effective March 15, 2023 The Supervisory Board of K+S Aktiengesellschaft has appointed Dr. Carin-Martina Tröltzsch as a further member of the Board of Executive Directors of the Company. She will assume her position at K+S on March 15, 2023. Dr. Christian H. Meyer, who was already appointed as the new Chief Financial Officer by the Supervisory Board of the Company in February of last year, will also take up his position on March 15, 2023, and will be responsible for the management and further development of the finance area at K+S. Dr. Burkhard Lohr, Chairman of the Board of Executive Directors, had assumed this role on a transitional basis in recent months. Aankondiging • Nov 13
K+S Aktiengesellschaft to Report Q3, 2022 Results on Nov 14, 2023 K+S Aktiengesellschaft announced that they will report Q3, 2022 results at 7:00 AM, Central European Standard Time on Nov 14, 2023 Reported Earnings • Aug 12
Second quarter 2022 earnings released: EPS: €1.93 (vs €0.78 in 2Q 2021) Second quarter 2022 results: EPS: €1.93 (up from €0.78 in 2Q 2021). Revenue: €1.51b (up 127% from 2Q 2021). Net income: €370.3m (up 147% from 2Q 2021). Profit margin: 25% (up from 23% in 2Q 2021). Over the next year, revenue is forecast to grow 16%, compared to a 14% growth forecast for the industry in Italy. Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth. Aankondiging • Aug 12
K+S Aktiengesellschaft to Report Q2, 2023 Results on Aug 10, 2023 K+S Aktiengesellschaft announced that they will report Q2, 2023 results on Aug 10, 2023 Reported Earnings • May 13
First quarter 2022 earnings released First quarter 2022 results: Revenue: €1.21b (up 65% from 1Q 2021). Net income: €310.9m (up 44% from 1Q 2021). Profit margin: 26% (down from 29% in 1Q 2021). Over the next year, revenue is forecast to grow 46%, compared to a 17% growth forecast for the industry in Italy. Aankondiging • May 12
K+S Aktiengesellschaft to Report Q1, 2023 Results on May 09, 2023 K+S Aktiengesellschaft announced that they will report Q1, 2023 results on May 09, 2023 Upcoming Dividend • May 06
Upcoming dividend of €0.20 per share Eligible shareholders must have bought the stock before 13 May 2022. Payment date: 17 May 2022. Trailing yield: 0.6%. Lower than top quartile of Italian dividend payers (4.8%). Lower than average of industry peers (3.3%). Valuation Update With 7 Day Price Move • Apr 11
Investor sentiment improved over the past week After last week's 17% share price gain to €32.67, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 15x in the Chemicals industry in Europe. Total returns to shareholders of 84% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €33.62 per share. Buying Opportunity • Mar 29
Now 22% undervalued Over the last 90 days, the stock is up 67%. The fair value is estimated to be €32.95, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 18% per annum over the last 3 years. The company has become profitable over the last year. Valuation Update With 7 Day Price Move • Mar 21
Investor sentiment improved over the past week After last week's 18% share price gain to €27.62, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 15x in the Chemicals industry in Europe. Total returns to shareholders of 66% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €33.10 per share. Reported Earnings • Mar 11
Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat Full year 2021 results: EPS: €11.36 (up from €9.88 loss in FY 2020). Revenue: €3.21b (up 32% from FY 2020). Net income: €2.17b (up €4.06b from FY 2020). Profit margin: 68% (up from net loss in FY 2020). The move to profitability was primarily driven by lower expenses. Revenue exceeded analyst estimates by 2.3%. Over the next year, revenue is forecast to grow 28%, compared to a 12% growth forecast for the industry in Italy. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has increased by 17% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Mar 02
Investor sentiment improved over the past week After last week's 16% share price gain to €23.69, the stock trades at a forward P/E ratio of 4x. Average forward P/E is 16x in the Chemicals industry in Europe. Total returns to shareholders of 45% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €26.40 per share. Reported Earnings • Nov 15
Third quarter 2021 earnings released: EPS €6.64 (vs €10.26 loss in 3Q 2020) Third quarter 2021 results: Revenue: €746.3m (down 9.2% from 3Q 2020). Net income: €1.27b (up €3.23b from 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings. Reported Earnings • Aug 18
Second quarter 2021 earnings released: EPS €0.78 (vs €0.019 loss in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: €664.2m (up 13% from 2Q 2020). Net income: €149.9m (up €153.6m from 2Q 2020). Profit margin: 23% (up from net loss in 2Q 2020). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 102 percentage points per year, which is a significant difference in performance. Reported Earnings • May 14
First quarter 2021 earnings released: EPS €1.13 (vs €0.33 loss in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: €733.3m (up 13% from 1Q 2020). Net income: €215.7m (up €278.9m from 1Q 2020). Profit margin: 29% (up from net loss in 1Q 2020). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 104 percentage points per year, which is a significant difference in performance. Is New 90 Day High Low • Jan 04
New 90-day high: €8.44 The company is up 19% from its price of €7.10 on 06 October 2020. The Italian market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €4.87 per share. Is New 90 Day High Low • Nov 27
New 90-day high: €7.81 The company is up 26% from its price of €6.19 on 28 August 2020. The Italian market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €18.95 per share. Reported Earnings • Nov 13
Third quarter 2020 earnings released: €10.26 loss per share The company reported a poor third quarter result with increased losses and weaker revenues and control over expenses. Third quarter 2020 results: Revenue: €821.7m (down 9.2% from 3Q 2019). Net loss: €1.96b (loss widened €1.91b from 3Q 2019). Over the last 3 years on average, earnings per share has fallen by 132% per year but the company’s share price has only fallen by 32% per year, which means it has not declined as severely as earnings. Analyst Estimate Surprise Post Earnings • Nov 13
Revenue misses expectations Revenue missed analyst estimates by 1.4%. Over the next year, revenue is forecast to grow 3.2% while the growth in Chemicals industry in Italy is expected to stay flat. Is New 90 Day High Low • Sep 22
New 90-day low: €5.25 The company is down 10.0% from its price of €5.85 on 24 June 2020. The Italian market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €16.81 per share.